Safety and Efficacy of Autologous PRP and PPP Eye Drops in the Treatment of Ocular GVHD
Condition(s):Graft-versus-host DiseaseLast Updated:August 28, 2017Withdrawn
Hide Studies Not Open or Pending
Condition(s):Graft-versus-host DiseaseLast Updated:August 28, 2017Withdrawn
Condition(s):Allergic ConjunctivitisLast Updated:September 14, 2020Completed
Condition(s):Dry Eye; Dry Eye Disease; Kerato Conjunctivitis SiccaLast Updated:March 27, 2024Completed
Condition(s):Glaucoma; Ocular HypertensionLast Updated:April 17, 2019Completed
Condition(s):BlepharitisLast Updated:November 21, 2013Terminated
Condition(s):Fuchs’ Corneal Endothelial Dystrophy (FCED)Last Updated:September 17, 2021Completed
Condition(s):BlepharoptosisLast Updated:September 16, 2020Completed
Condition(s):Dry EyeLast Updated:December 7, 2020Completed
Condition(s):BlepharoptosisLast Updated:September 16, 2020Completed
Condition(s):Geographic Atrophy; Age-Related Macular Degeneration; AMDLast Updated:July 14, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.